All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @astoldbyautumnn on TikTok · 25s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @astoldbyautumnn's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Let's see if you can spot the difference. This was six weeks ago at the beginning of my
  2. 0:04semi-glutide journey with Gitwell Concierge and my main goal with starting semi-glutide
  3. 0:09is just to look and feel better in all of my clothes because I definitely was not feeling the
  4. 0:13way that this looked here. I'm around 12 pounds down and I can definitely tell a difference but
  5. 0:18let me know. Can you tell a difference? If you want to get started with semi-glutide, click the link in my bio.

@astoldbyautumnn's semaglutide journey, fact-checked

Autumn Nicaleh

TikTok creator

543.5K viewsWatch on TikTok

Quick answer

The creator reports approximately 12 pounds of weight loss over 6 weeks on semaglutide prescribed through Gitwell Concierge, a telehealth provider. This rate is within the upper range of early-phase results seen in clinical trials but is not the average outcome. No dose, formulation type, or side effect information is disclosed, which limits the clinical relevance of the comparison for viewers considering treatment.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @astoldbyautumnn's semaglutide journey, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

Compounded Semaglutide should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@astoldbyautumnn's semaglutide journey, fact-checked" from Autumn Nicaleh. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator reports approximately 12 pounds of weight loss over 6 weeks on semaglutide prescribed through Gitwell Concierge, a telehealth provider.

The reason this review is not generic is the source wording and the canonical claim label "glp1 week 6 of semaglutide can you spot the difference i m." In this clip, the useful excerpt is: "Let's see if you can spot the difference." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

30-44% of semaglutide patients in clinical trials experience nausea or other GI side effects (Davies et al.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator reports approximately 12 pounds of weight loss over 6 weeks on semaglutide prescribed through Gitwell Concierge, a telehealth provider.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator reports approximately 12 pounds of weight loss over 6 weeks on semaglutide prescribed through Gitwell Concierge, a telehealth provider. This rate is within the upper range of early-phase results seen in clinical trials but is not the average outcome. No dose, formulation type, or side effect information is disclosed, which limits the clinical relevance of the comparison for viewers considering treatment.
  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of 14.9% over 68 weeks on semaglutide, meaning 12 lbs in 6 weeks is possible but above average for most patients.
  • 30-44% of semaglutide patients in clinical trials experience nausea or other GI side effects (Davies et al., 2021, Lancet), a fact absent from this video.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of 14.9% over 68 weeks on semaglutide, meaning 12 lbs in 6 weeks is possible but above average for most patients.
  • 30-44% of semaglutide patients in clinical trials experience nausea or other GI side effects (Davies et al., 2021, Lancet), a fact absent from this video.
  • The STEP 4 withdrawal trial (Rubino et al., 2021, JAMA) found that patients regained two-thirds of lost weight within one year of stopping semaglutide. This drug requires long-term use to maintain results.
  • Compounded semaglutide dispensed by telehealth platforms is not FDA-approved and is not considered equivalent to brand-name Wegovy or Ozempic. The FDA issued safety warnings about compounded versions in 2023 and 2024.
  • Semaglutide dose is titrated over 16-20 weeks to reach a therapeutic level. Week 6 results reflect early-dose effects, not the full treatment effect.
  • Individual outcomes on semaglutide vary widely. Starting weight, metabolic health, diet, and physical activity all significantly affect results, none of which are discussed in this video.
  • Telehealth prescribing of semaglutide is legal when conducted by a licensed provider with appropriate clinical oversight, but viewers should verify what formulation they are being prescribed before starting treatment.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @astoldbyautumnn actually say?

The creator said she's "around 12 pounds down" after six weeks on semaglutide through a service called Gitwell Concierge, and that her goal was to "look and feel better in all of my clothes." She didn't make any dramatic medical claims. She didn't say semaglutide cured anything, promise a specific outcome to viewers, or give dosing advice. For a weight-loss TikTok, that's actually pretty restrained.

What she did do is drop a direct call-to-action: "click the link in my bio" to get started with semaglutide. That's an implicit endorsement of a specific provider, which is worth noting. The video is essentially a before/after post with a referral embedded in it. The 12-pound figure is the only concrete, verifiable claim in the video, so that's where the science conversation needs to happen.

Does the science back this up?

Twelve pounds in six weeks is on the higher end of what the clinical literature predicts, but it's not impossible, especially early in treatment when water weight and appetite suppression combine. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed an average of 14.9% body weight loss over 68 weeks, which works out to roughly 1-2 lbs per week at peak effect.

Early weeks tend to produce faster loss for some patients. A 2022 analysis by Rubino et al. in JAMA found that patients lost approximately 6% of body weight in the first 12 weeks. At that rate, 12 lbs in 6 weeks would require a starting weight of around 200 lbs, which is plausible but assumes her results are at the upper bound of the distribution. Individual variation is real. Genetics, baseline weight, starting dose, diet, and activity all shift outcomes significantly. So: possible, not typical, not fabricated.

What did they get wrong (or right)?

She got the emotional framing right. Saying she was nervous about what people would "think" about using semaglutide reflects a real and documented barrier to treatment. Stigma around pharmacological weight loss is well-studied, and it keeps people from pursuing medically appropriate options (Puhl and Heuer, 2010, Obesity Reviews).

What she glossed over is everything that matters clinically. There's no mention of side effects, which for semaglutide are not trivial. Nausea, vomiting, and gastrointestinal distress are reported in 30-44% of patients in clinical trials (Davies et al., 2021, Lancet). There's no mention that results vary, that the drug is titrated over weeks, or that stopping semaglutide typically leads to weight regain, as shown in the STEP 4 withdrawal trial (Rubino et al., 2021, JAMA). A 543,000-view video that ends with "click the link in my bio" has some responsibility to include that context, and it doesn't.

What should you actually know?

Semaglutide is a legitimate, FDA-approved medication for chronic weight management under the brand name Wegovy, and for type 2 diabetes as Ozempic. The clinical evidence behind it is strong. The STEP trial series consistently showed meaningful weight loss that outperformed prior pharmacological options. This is not a supplement or a fad, it is a regulated drug with a real mechanism of action.

But "telehealth semaglutide" accessed through a link in a TikTok bio exists in complicated regulatory territory. Compounded semaglutide, which many telehealth platforms dispense, is not the same as FDA-approved brand-name semaglutide. The FDA has explicitly flagged compounded semaglutide as a safety concern. You should ask any prescribing platform exactly what they are dispensing, at what dose, and what their clinical oversight looks like. A 6-week transformation video is not a substitute for a prescriber who knows your medical history.

Weight loss of 12 lbs in 6 weeks is physically achievable on semaglutide for some patients. It is not guaranteed. Expect the first 4-6 weeks to involve dose titration and side effect management, not just results.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Autumn Nicaleh · TikTok creator

543.5K views on this video

Week 6 of Semaglutide - can you spot the difference? 🫣 I'm not embarrassed to talk about this my experience because I get so many DMs from people asking how things are going and how they can try it o

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the step 1 trial (wilding et al., 2021, nejm) showed?

The STEP 1 trial (Wilding et al., 2021, NEJM) showed average weight loss of 14.9% over 68 weeks on semaglutide, meaning 12 lbs in 6 weeks is possible but above average for most patients.

What does the video say about 30-44% of semaglutide patients in clinical trials experience nausea?

30-44% of semaglutide patients in clinical trials experience nausea or other GI side effects (Davies et al., 2021, Lancet), a fact absent from this video.

What does the video say about the step 4 withdrawal trial (rubino et al., 2021, jama)?

The STEP 4 withdrawal trial (Rubino et al., 2021, JAMA) found that patients regained two-thirds of lost weight within one year of stopping semaglutide. This drug requires long-term use to maintain results.

What does the video say about compounded semaglutide dispensed by telehealth platforms?

Compounded semaglutide dispensed by telehealth platforms is not FDA-approved and is not considered equivalent to brand-name Wegovy or Ozempic. The FDA issued safety warnings about compounded versions in 2023 and 2024.

What does the video say about semaglutide dose?

Semaglutide dose is titrated over 16-20 weeks to reach a therapeutic level. Week 6 results reflect early-dose effects, not the full treatment effect.

What does the video say about individual outcomes on semaglutide vary widely. starting weight, metabolic health,?

Individual outcomes on semaglutide vary widely. Starting weight, metabolic health, diet, and physical activity all significantly affect results, none of which are discussed in this video.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Autumn Nicaleh, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.